Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Aerts

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
Cancer Chemotherapy and Pharmacology|June 25, 2022
Impact of pharmacogenetics on variability in exposure to oral vinorelbine among pediatric patients: a model-based population pharmacokinetic analysisMourad Hamimed, Pierre Leblond, Aurélie Dumont, et al.
Cancers|April 13, 2023
Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX)Pierre Leblond, Emmanuelle Tresch-Bruneel, Alicia Probst, et al.
Neuro-Oncology|July 17, 2013
Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor studyJacques Grill, Birgit Geoerger, Lyle Gesner, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 16, 2025
A functional assay to classify RB1 variants of uncertain significanceJessica Le Gall, Catherine Dehainault, Ambre Petitalot, et al.
Journal of Neuro-Oncology|July 18, 2012
Trilateral retinoblastoma: neuroimaging characteristics and value of routine brain screening on admissionFirazia Rodjan, Pim de Graaf, Hervé J Brisse, et al.
Targeted Oncology|June 17, 2022
Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II StudyTanya Trippett, Helen Toledano, Quentin Campbell Hewson, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2010
Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium StudyBirgit Geoerger, Julia Chisholm, Marie-Cecile Le Deley, et al.
Journal of Neuro-Oncology|December 14, 2017
Outcome of children and adolescents with central nervous system tumors in phase I trialsFernando Carceller, Francisco Bautista, Irene Jiménez, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2010
Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumoursHervé Rubie, Birgit Geoerger, Didier Frappaz, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 2016
Prognostic factors of overall survival in children and adolescents enrolled in dose-finding trials in Europe: An Innovative Therapies for Children with Cancer studyFernando Carceller, Francisco J Bautista, Irene Jiménez, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Cancer Chemotherapy and Pharmacology|June 25, 2022
Impact of pharmacogenetics on variability in exposure to oral vinorelbine among pediatric patients: a model-based population pharmacokinetic analysisMourad Hamimed, Pierre Leblond, Aurélie Dumont, et al.
Cancers|April 13, 2023
Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX)Pierre Leblond, Emmanuelle Tresch-Bruneel, Alicia Probst, et al.
Neuro-Oncology|July 17, 2013
Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor studyJacques Grill, Birgit Geoerger, Lyle Gesner, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 16, 2025
A functional assay to classify RB1 variants of uncertain significanceJessica Le Gall, Catherine Dehainault, Ambre Petitalot, et al.
Journal of Neuro-Oncology|July 18, 2012
Trilateral retinoblastoma: neuroimaging characteristics and value of routine brain screening on admissionFirazia Rodjan, Pim de Graaf, Hervé J Brisse, et al.
Targeted Oncology|June 17, 2022
Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II StudyTanya Trippett, Helen Toledano, Quentin Campbell Hewson, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2010
Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium StudyBirgit Geoerger, Julia Chisholm, Marie-Cecile Le Deley, et al.
Journal of Neuro-Oncology|December 14, 2017
Outcome of children and adolescents with central nervous system tumors in phase I trialsFernando Carceller, Francisco Bautista, Irene Jiménez, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2010
Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumoursHervé Rubie, Birgit Geoerger, Didier Frappaz, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 2016
Prognostic factors of overall survival in children and adolescents enrolled in dose-finding trials in Europe: An Innovative Therapies for Children with Cancer studyFernando Carceller, Francisco J Bautista, Irene Jiménez, et al.
Pageof 13